Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.
View Top Employees from Ocugen| Website | https://www.ocugen.com |
| Revenue | $3 million |
| Funding | $13.5 million |
| Employees | 88 (88 on RocketReach) |
| Founded | 2013 |
| Address | 263 Great Valley Pkwy, Malvern, Pennsylvania 19355, US |
| Phone | (484) 328-4701 |
| Technologies |
JavaScript,
HTML,
PHP
+44 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Ophthalmology, Healthcare, Biopharmaceutical, Biotechnology, Therapeutics Biologics, Rare Diseases, Inherited Retinal Disorders, Wet Amd |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Ocugen employee's phone or email?
Ocugen Questions
The Ocugen annual revenue was $3 million in 2024.
Arun Upadhyay is the Chief Scientific Officer of Ocugen.
88 people are employed at Ocugen.
Ocugen is based in Malvern, Pennsylvania.
The NAICS codes for Ocugen are [3254, 32, 32541, 325].
The SIC codes for Ocugen are [28, 283].
Top Ocugen Employees
-
41
-
44
-
21
-
15
-
21
-
12
-
32
-
31
-
32
-
12
Related Companies
